Stockscreener 앱 받기
25.20
1.06%
-0.2689
전일 마감가:
$25.47
열려 있는:
$25.31
하루 거래량:
3,747
Relative Volume:
5.71
시가총액:
$6.90M
수익:
$64.22M
순이익/손실:
$-373.46M
주가수익비율:
-10.33
EPS:
-2.44
순현금흐름:
$-157.61M
1주 성능:
+57,976%
1개월 성능:
+57,976%
6개월 성능:
+57,976%
1년 성능:
+57,976%
1일 변동 폭
$25.20
$25.31
1주일 범위
$24.88
$25.47
52주 변동 폭
$24.88
$25.47
Cue Health Inc Stock (HLTH) Company Profile
명칭
Cue Health Inc
전화
858-412-8151
주소
4980 Carroll Canyon Road, Suite 100, San Diego
Compare HLTH vs VEEV, BTSG, HQY, TEM, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HLTH
Cue Health Inc
|
25.20 | 6.90M | 64.22M | -373.46M | -157.61M | -2.44 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Cue Health Inc 주식(HLTH)의 최신 뉴스
Tema's AI ETF Targets Drug Discovery, Diagnostics and Robotics - Stock Titan
TUBI APPOINTS SHANNON OLIVAS AS HEAD OF COMMUNICATIONS AND PUBLICITY - Tubi
Needham reiterates Hold on Conmed stock amid sale exploration - Investing.com
Cue Biopharma names Dominic Borie as chief medical officer - Investing.com
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development - Yahoo Finance
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
Cue Biopharma (Nasdaq: CUE) secures $50M private placement and grants over 1M RSUs - Stock Titan
Cue: The Market Is Paying $86M For A Drug It Doesn't Own (NASDAQ:CUE) - Seeking Alpha
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Biotech firm Cue Biopharma lines up $50M to push its immune disorder drugs - Stock Titan
Cue Health Inc. Actuals & Estimates (OTC:HLTHQ) - TradingView
Cue Biopharma Inc (CUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Temasek’s CFO is moving into a new power role - Fortune
Conmed Names John Gallagher as New Chief Financial Officer - The Globe and Mail
Cue Biopharma (NASDAQ: CUE) registers 551,724 pre-funded-warrant shares for resale - Stock Titan
CONMED Appoints John E. Gallagher as New Chief Financial Officer, Effective July 2026 - Minichart
Conmed names John Gallagher as CFO effective July 15 By Investing.com - Investing.com Australia
Conmed names John Gallagher as CFO effective July 15 - Investing.com
CONMED (NYSE: CNMD) hires John Gallagher as CFO with equity-heavy pay - Stock Titan
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer - Business Wire
Cue Biopharma Inc (CUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cue Biopharma Inc (CUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cue Biopharma Inc (CUE) Institutional Confidence - TradingKey
Cue Biopharma, Inc. (CUE) Latest Stock News & Headlines - Yahoo Finance
Cue Biopharma adds two directors as four board members resign - Investing.com UK
CUE - Finviz
Apple’s Top Executive Uses a Whoop — What That Says About the Company’s $100 Billion Apple Watch Problem - Yahoo Finance
CUE Stock Price, Quote & Chart | CUE BIOPHARMA INC (NASDAQ:CUE) - ChartMill
Cue Biopharma CEO to present at Jefferies healthcare conference in NYC - Stock Titan
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference - Yahoo Finance
Why Is Cue Health Inc. (HLTHQ) Stock Down Today? - Meyka
Cue Biopharma reports Q1 loss, secures $30M financing - Investing.com UK
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments - The Manila Times
Cue Biopharma (CUE) boosts Q1 revenue, raises $30M and trims net loss - Stock Titan
[10-Q] Cue Biopharma, Inc. Quarterly Earnings Report - Stock Titan
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
New Cue Biopharma CEO gets 655,074-share option and 327,537 stock units - Stock Titan
CUE stock jumps over 100% after hours — what’s driving the rally? - MSN
Cue Biopharma Secures Exclusive License for Dual-Mechanism Anti-IgE Antibody, Expanding Pipeline for Allergic and Autoimmune Diseases - Minichart
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Cue Biopharma stock surges over 65% overnight: Why is it moving? - MSN
Cue Biopharma raises $30M in private placement - MSN
Cue Biopharma jumps as investors react to Ascendant-221 licensing deal and fresh financing news | CUE Stock News - Quiver Quantitative
Cue pays $15M for allergy drug, targets food allergy trial - Stock Titan
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody - The Manila Times
Two board hires back Made Scientific’s move toward commercial cell therapy - Stock Titan
Cue Biopharma licenses anti-IgE antibody for allergic diseases - Investing.com
Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN
Cue Biopharma’s Nasdaq Move Signals Strategic Share Realignment - Kalkine Media
12 Health Care Stocks Moving In Tuesday's Intraday SessionFirefly Neuroscience (NASDAQ:AIFF), AIxCrypt - Benzinga
Cue Biopharma (CUE) Appoints Lucinda Warren as Interim President and CEO - Yahoo Finance
Cue Health Inc (HLTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.99%
2.12%
자본화:
|
볼륨(24시간):